By A monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, according to new research published in The Lancet Infectious Diseases by researchers at the University of Maryland School of Medicine (UMSOM).
Small study shows promise for antimalarial monoclonal antibody to prevent malaria
Focused chemists in lab coats and safety goggles making experiments.
Comments